Alucent Biomedical, Inc.
New Filing
CIK: 0001631834·Biotechnology·DELAWARE·Filed: Oct 15, 2020
Total Offering
$34,999,999
Amount Sold
$34,999,999
Investors
3
First Sale
Sep 30, 2020
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Myles D. Greenberg | Related Person |
| James Corbett | Related Person |
| Dan Pelak | Related Person |
| Ryan Hansen | Related Person |
| Pat Costello | Related Person |
| Julie N. Lautt | Related Person |
| David Flicek | Related Person |
| Scott Mayfield | Related Person |
Company
SEC Filing
0001631834-20-000004
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free